 |
| MAY
9, 2025 |
| Covering
Life Sciences Drugs, Diagnostics, Devices,
Digital Health |
|
|
|
* may need subscription to view |
 |
| Boston's
most flexible contract vivarium
lab space: Start with a few study
cages and grow. |
|
Learn More
→ |
|
|
- Artax Biopharma: Presents Phase 2a Results
for Oral Nck Modulator AX-158 in Late-breaking
Session at the Society for Investigative
Dermatology 2025 Annual Meeting More
- Garuda Therapeutics: Name Change to
Stratus Therapeutics to Reflect Mission of
Pioneering Full Hematopoietic System Renewal
More
- Keros: Reinforces Commitment to Maximizing
Stockholder Value More
- Kymera Therapeutics: Expands Industry
Leading Immunology Pipeline With New
First-in-Class, Oral IRF5 Degrader Program
With Potential to Address Multiple
Immuno-Inflammatory Diseases More
- Kytopen and Bio-Techne: Collaborate on an
Integrated Cellular Engineering Workflow to
Expedite Cell Therapy Manufacturing More
- PureTech: Publication of New Research
Highlighting Untold Experiences of People
Living With Idiopathic Pulmonary Fibrosis
(IPF) More
- Ratio Therapeutics: Will Establish New
Radiopharmaceutical Manufacturing Facility More
- Rectify Pharma: Presents Translational Data
for Novel Positive Functional Modulator
Demonstrating Improved Biliary and Liver
Health at EASL 2025 More
- TransCode Therapeutics: Successfully
Completes Initial Dosing of Patients in Cohort
4 of Phase 1a Clinical Trial; No Dose Limiting
Toxicities Reported More
- Verastem: FDA Approves the AVMAPKI
FAKZYNJA Combination Therapy as the
First-Ever Treatment for Adult Patients With
KRAS-mutated Recurrent Low-Grade Serous
Ovarian Cancer More
More*
|
|
 |
Strategic
CFO Services for Scaling Biotech
Startups
Explore how biotech startups can
leverage fractional CFO services
to scale efficiently |
|
Learn More
→ |
|
|
- Collegium: First Quarter 2025 Financial
Results and Highlights Recent Company Progress
More
- Galecto: First Quarter 2025 Operating and
Financial Results More
- Insulet: First Quarter 2025 Revenue Increase
of 29% Year-Over-Year (30% Constant Currency1)
More
- Kymera Therapeutics: First Quarter 2025
Financial Results and Provides a Business
Update More
- MetaVia: $10.0 Million Private Placement
Priced At-The-Market Under Nasdaq Rules More
- More on Korro Laying Off 20% of Staff to
Fund Genetic Med Trials, Novo Nordisk
Partnership More
- Organogenesis: First Quarter 2025 Financial
Results More
- Prime Medicine: First Quarter 2025 Financial
Results and Provides Business Updates More
- Spyre Therapeutics: First Quarter 2025
Financial Results and Provides Corporate
Update More
- Tectonic Therapeutic: First Quarter 2025
Financial Results and Recent Business
Highlights More
- TransMedics: First Quarter 2025 Financial
Results More
- uniQure: First Quarter 2025 Financial
Results and Highlights of Recent Company
Progress More
- Vericel: First Quarter 2025 Financial
Results and Raises Full-Year Profitability
Guidance More
- Vor Bio: Exploration of Strategic
Alternatives to Maximize Shareholder Value More
More
More*
More*
|
|
|
- Leveraging Synergies: How a Merger
Provides Speed, Flexibility, and a Unified
Offering for Customers Podcast
- Lila Sciences Plans Hiring Spree in
Massachusetts for 'Scientific
Superintelligence' Venture More*
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Boston Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
Feature your company |
|
Apply to have your company
highlighted on our
website. |
|
|
|
|
|
|
NOTE: EVENTS AND JOBS ARE FROM
ALL BIG4BIO REGIONS
 |
|
Premier Executive Search and
Talent Advisory Firm Slone
Partners Launches Fractional
Talent Service to Deliver
On-Demand Leaders and Specialists
|
|
Learn More
→ |
|
|
- OPPORTUNITY: Chief Executive Officer More
- OPPORTUNITY: Chief Product Officer More
- OPPORTUNITY: Vice President, Digital Health
Business Development More
- OPPORTUNITY: Chief Business Officer More
- OPPORTUNITY: Vice President, Finance More
- OPPORTUNITY: Director, Compliance &
Quality Systems More
- OPPORTUNITY: West Coast Business Development
Director More
- OPPORTUNITY: Chief Financial Officer More
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Boston,
all rights reserved 2025
© 2025
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
